KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS)

CUSIP: G52441105

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class
Equity / COMMON STOCK
Total 13F shares
2,730,091
Total 13F value
$77,234,275
Holder snapshot 6 signals
Share change
-168
SEC-reported price per share
$28.29
Number of holders
6
Value change
-$4,753
Number of buys
1
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
58,457,647

Security key

G52441105

Report period

Q3 2026

Institutions

6

Top holders

6

KMTS full security history Ownership snapshot Full 13F holder table Previous quarter: Q2 2026 KESTRA MEDICAL TECHNOLOGIES, LTD. SEC filings KESTRA MEDICAL TECHNOLOGIES, LTD. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bain Charger Holdings, L.P.
Disclosed value leader
Jeffrey Lawrence Schwartz
Comparable rows
15/15
Latest evidence
30 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 43% 13D/G row: Bain Charger Holdings, L.P. Showing 1-6 of 15 holder rows.

Quick read

Bain Charger Holdings, L.P. leads the comparable SEC ownership view at 43%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Charger Holdings, L.P.'s linked filing trail.
Comparable ownership Top 5
Bain Charger Holdings, L.P. 43%
FMR LLC 10%
PRICE T ROWE ASSOCIATES INC /MD/ 8.5%
Endeavour Medtech Growth II LP 4.2%
Jeffrey Lawrence Schwartz 43%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bain Charger Holdings, L.P.
13D/G
13D/G
43%
$554,798,330
25,172,338 shares
 -$40,705,389 31 Dec 2025
FMR LLC
13F 13D/G
Company
13F 13D/G
10%
from 13D/G
$140,521,580
5,523,647 shares
 — 30 Jun 2026
PRICE T ROWE ASSOCIATES INC /MD/
13F 13D/G
Company · T. Rowe Price Associates, Inc.
13F 13D/G
8.5%
from 13D/G
$126,410,000
4,968,900 shares
 — 30 Jun 2026
Endeavour Medtech Growth II LP
13D/G
13D/G
4.2%
$53,974,682
2,448,942 shares
 -$4,362,972 31 Dec 2025
Jeffrey Lawrence Schwartz
3/4/5
Director, 10%+ Owner
3/4/5
43%
$640,746,441
25,186,574 shares
 -$97,942 08 Sep 2026
Timothy P. Moran
3/4/5
Chief Business Officer
3/4/5
0.11%
$1,576,430
66,345 shares
 -$348,311 30 Jul 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
6
Shares
2,730,091
Rows available
6
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
107
Q3 2026 holders
6
Holder diff
-101
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .